S&P 500 6,976.44 ▲ 37.41 (+0.54%)
DOW 49,407.66 ▲ 515.19 (+1.05%)
NASDAQ 23,592.11 ▲ 130.29 (+0.56%)
US Markets Closed

XAGEW

Longevity Health Holdings, Inc.

Price Chart

No historical data available

Latest Quote

$0.01

Current Price
Previous Close $0.01
Open $0.01
Day High $0.01
Day Low $0.01
Volume 16,099
Fetched: 2026-02-03T07:31:44
Stock Information
Total Debt $619K
Cash Equivalents $1.11M
Revenue $1.46M
Net Income $-5.74M
Exchange NCM
🌐 Visit Website
📊 Custom Metrics & Score
Score: 13/42
Debt to Equity -0.14
Debt to Earnings 14.54
Current Ratio 0.16
Quick Ratio 0.08
Profit Margin -20605.47%
Return on Equity 220.01%
Avg FCF Growth 67.66%
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
No history data available. Data will be fetched automatically.
About Longevity Health Holdings, Inc.

Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Income Statement (Annual)
Revenue
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Reconciled Cost Of Revenue $6,357 $0 - -
Cost Of Revenue $6,357 $0 - -
Total Revenue $50,318 $0 $0 $0
Operating Revenue $90,829 $0 $0 $0
Expenses
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Interest Expense $49,015 $889,318 $3,749,210 $2,499,084
Total Expenses $5,048,816 $5,217,276 $5,507,641 $1,940,332
Other Income Expense $-5,700,230 $-10,098,658 $205,517 $-2,039,507
Other Non Operating Income Expenses $44,798 $68,772 $10,922 $37,378
Net Non Operating Interest Income Expense $-49,015 $-889,318 $-3,749,210 $-2,499,084
Interest Expense Non Operating $49,015 $889,318 $3,749,210 $2,499,084
Operating Expense $5,042,459 $5,217,276 $5,507,641 $1,940,332
Selling And Marketing Expense $189,323 $0 - -
General And Administrative Expense $3,715,340 $2,622,945 $3,217,280 $863,333
Total Other Finance Cost - - $2,044,241 $1,783,597
Income & Earnings
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Net Income From Continuing Operation Net Minority Interest $-10,650,464 $-16,205,252 $-9,051,334 $-6,478,923
Net Interest Income $-49,015 $-889,318 $-3,749,210 $-2,499,084
Normalized Income $-4,957,141 $-6,037,822 $-9,245,929 $-4,402,038
Net Income From Continuing And Discontinued Operation $-10,368,261 $-15,445,087 $-9,051,334 $-6,478,923
Total Operating Income As Reported $-4,998,498 $-5,943,556 $-5,507,641 $-1,940,332
Net Income Common Stockholders $-10,368,261 $-16,121,110 $-9,607,835 $-6,786,850
Net Income $-10,368,261 $-15,445,087 $-9,051,334 $-6,478,923
Net Income Including Noncontrolling Interests $-10,368,261 $-15,445,087 $-9,051,334 $-6,478,923
Net Income Discontinuous Operations $282,203 $760,165 $0 -
Net Income Continuous Operations $-10,650,464 $-16,205,252 $-9,051,334 $-6,478,923
Pretax Income $-10,747,743 $-16,205,252 $-9,051,334 $-6,478,923
Special Income Charges $-44,577 $-726,280 $-1,064,692 $438,180
Operating Income $-4,998,498 $-5,217,276 $-5,507,641 $-1,940,332
Depreciation Amortization Depletion Income Statement $83,486 $97,113 $94,298 $94,162
Depreciation And Amortization In Income Statement $83,486 $97,113 $94,298 $94,162
Amortization Of Intangibles Income Statement $83,486 $97,113 - -
Gross Profit $43,961 $0 - -
Other
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Tax Effect Of Unusual Items $-51,705 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-4,756,440 $-5,023,716 $-5,254,163 $-1,660,830
Total Unusual Items $-5,745,028 $-10,167,430 $194,595 $-2,076,885
Total Unusual Items Excluding Goodwill $-5,745,028 $-10,167,430 $194,595 $-2,076,885
Reconciled Depreciation $197,260 $124,788 $242,556 $242,124
EBITDA (Bullshit earnings) $-10,501,468 $-15,191,146 $-5,059,568 $-3,737,715
EBIT $-10,698,728 $-15,315,934 $-5,302,124 $-3,979,839
Diluted NI Availto Com Stockholders $-10,368,261 $-16,121,110 $-9,607,835 $-6,786,850
Tax Provision $-97,279 $0 $0 $0
Other Special Charges $44,577 - $1,064,692 $-438,180
Restructuring And Mergern Acquisition $0 $726,280 $0 -
Gain On Sale Of Security $-5,700,451 $-9,441,150 $1,259,287 $-2,515,065
Amortization $83,486 $97,113 - -
Research And Development $1,054,310 $2,497,218 $2,196,063 $982,837
Selling General And Administration $3,904,663 $2,622,945 $3,217,280 $863,333
Other Gand A $3,715,340 $2,622,945 $3,217,280 $863,333
Preferred Stock Dividends - $676,023 $556,501 $307,927
Fetched: 2026-02-02
Balance Sheet (Annual)
Assets
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Net Tangible Assets $-4,732,303 $24,724,823 $-37,819,241 $-29,610,264
Total Assets $1,473,980 $63,948,803 $1,748,547 $1,557,103
Total Non Current Assets $518,426 $1,048,689 $1,143,007 $1,378,399
Goodwill And Other Intangible Assets $19,641 $24,187 $28,702 $33,218
Other Intangible Assets $19,641 $24,187 $28,702 $33,218
Current Assets $955,554 $62,900,114 $605,540 $178,704
Hedging Assets Current $0 $5,700,451 $0 -
Assets Held For Sale Current $0 $53,321,372 $0 -
Current Deferred Assets $86,314 $0 $394,147 $166,342
Prepaid Assets $297,462 $761,271 $55,069 $0
Inventory $108,705 $0 - -
Receivables $305,934 $204,559 $0 -
Taxes Receivable $301,838 $204,559 $0 -
Accounts Receivable $4,096 $0 - -
Cash Cash Equivalents And Short Term Investments $157,139 $2,912,461 $128,149 $12,362
Cash And Cash Equivalents $157,139 $2,912,461 $128,149 $12,362
Cash Financial $157,139 $2,912,461 $128,149 $12,362
Other Current Assets - - $28,175 -
Debt
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Net Debt $84,019 - $2,649,629 $8,591,992
Total Debt $638,993 $2,136,449 $3,735,008 $9,686,424
Long Term Debt And Capital Lease Obligation $309,937 $697,715 $827,728 $962,830
Current Debt And Capital Lease Obligation $329,056 $1,438,734 $2,907,280 $8,723,594
Current Debt $241,158 $1,288,598 $2,777,778 $8,603,432
Other Current Borrowings $241,158 $1,288,598 $2,777,778 $8,603,432
Long Term Debt - - - $922
Liabilities
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Liabilities Net Minority Interest $6,186,642 $39,199,793 $39,539,086 $31,134,149
Total Non Current Liabilities Net Minority Interest $309,937 $697,715 $32,243,801 $15,330,784
Current Liabilities $5,876,705 $38,502,078 $7,295,285 $15,803,365
Payables And Accrued Expenses $5,547,649 $5,896,904 $2,644,091 $2,751,969
Interest Payable $1,175,845 $1,175,845 $477,720 $1,880,656
Payables $4,058,091 $4,417,234 $2,138,732 $871,313
Accounts Payable $4,058,091 $4,417,234 $2,138,732 $871,313
Other Current Liabilities - $29,874,831 $826,980 $3,838,008
Derivative Product Liabilities - - $0 $33,300
Equity
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Common Stock Equity $-4,712,662 $24,749,009 $-37,790,539 $-29,577,046
Total Equity Gross Minority Interest $-4,712,662 $24,749,010 $-37,790,539 $-29,577,046
Stockholders Equity $-4,712,662 $24,749,010 $-37,790,539 $-29,577,046
Retained Earnings $-68,871,662 $-58,503,401 $-42,382,291 $-32,774,456
Preferred Stock Equity - $1 - -
Preferred Securities Outside Stock Equity - $0 $31,416,073 $14,334,654
Other
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Ordinary Shares Number $696,846 $769,686 $641,210 $641,210
Share Issued $696,846 $769,686 $641,210 $641,210
Tangible Book Value $-4,732,303 $24,724,822 $-37,819,241 $-29,610,264
Invested Capital $-4,471,504 $26,037,607 $-35,012,761 $-20,972,692
Working Capital $-4,921,151 $24,398,036 $-6,689,745 $-15,624,661
Capital Lease Obligations $397,835 $847,851 $957,230 $1,082,070
Total Capitalization $-4,712,662 $24,749,010 $-37,790,539 $-29,576,124
Additional Paid In Capital $64,156,909 $83,250,101 $4,590,855 $3,160,491
Capital Stock $2,091 $2,310 $897 $36,919
Common Stock $2,091 $2,309 $897 $36,919
Preferred Stock $0 $1 $0 -
Long Term Capital Lease Obligation $309,937 $697,715 $827,728 $961,908
Current Capital Lease Obligation $87,898 $150,136 $129,502 $120,162
Pensionand Other Post Retirement Benefit Plans Current $0 $1,291,609 $916,934 $489,794
Current Accrued Expenses $1,489,558 $1,479,670 $505,359 $1,880,656
Net PPE $498,785 $1,024,502 $1,114,305 $1,345,181
Accumulated Depreciation $-701,655 $-622,715 $-530,116 $-440,334
Gross PPE $1,200,440 $1,647,217 $1,644,421 $1,785,515
Leases $115,333 $115,333 $115,333 $115,333
Other Properties $1,081,527 $1,528,304 $1,525,509 $1,670,182
Machinery Furniture Equipment $3,580 $3,580 $3,579 $0
Properties $0 $0 $0 $0
Treasury Shares Number - $0 - -
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Free Cash Flow
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow $-4,388,948 $-8,378,678 $-3,435,871 $-1,184,102
Operating Activities
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow $-4,388,948 $-8,348,208 $-3,428,707 $-1,176,829
Cash Flow From Continuing Operating Activities $-4,388,948 $-8,348,208 $-3,428,707 $-1,176,829
Operating Gains Losses $5,700,451 $9,441,150 $-194,595 $2,515,065
Investing Activities
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investing Cash Flow $-748,796 $-30,470 $-7,164 $-7,273
Cash Flow From Continuing Investing Activities $-748,796 $-30,470 $-7,164 $-7,273
Capital Expenditure - $-30,470 $-7,164 $-7,273
Financing Activities
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Issuance Of Capital Stock $2,687,225 $0 $1,064,317 $3,194
Financing Cash Flow $2,382,422 $11,162,990 $3,551,658 $1,195,314
Cash Flow From Continuing Financing Activities $2,382,422 $11,162,990 $3,551,658 $1,195,314
Net Other Financing Charges $-86,314 $12,463,644 $-402,554 $-166,342
Net Common Stock Issuance $2,687,225 $0 $-2,294 $3,194
Common Stock Issuance $2,687,225 $0 $0 $3,194
Repurchase Of Capital Stock - $0 $-2,294 $0
Net Preferred Stock Issuance - $0 $1,064,317 $0
Preferred Stock Issuance - $0 $1,064,317 $0
Other
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Repayment Of Debt $-714,181 $-3,201,707 $0 -
Issuance Of Debt $495,692 $1,859,980 $2,745,974 $1,124,299
Interest Paid Supplemental Data $29,466 $283,526 $92,593 $0
Income Tax Paid Supplemental Data $0 $750,000 $0 $0
End Cash Position $157,139 $2,912,461 $128,149 $12,362
Beginning Cash Position $2,912,461 $128,149 $12,362 $1,150
Changes In Cash $-2,755,322 $2,784,312 $115,787 $11,212
Proceeds From Stock Option Exercised $0 $41,073 $146,215 $234,163
Net Issuance Payments Of Debt $-218,489 $-1,341,727 $2,745,974 $1,124,299
Net Short Term Debt Issuance $-218,489 $-1,341,727 $2,745,974 $1,124,299
Short Term Debt Payments $-714,181 $-3,201,707 $0 -
Short Term Debt Issuance $495,692 $1,859,980 $2,745,974 $1,124,299
Net Business Purchase And Sale $-748,796 $0 - -
Purchase Of Business $-748,796 $0 - -
Net PPE Purchase And Sale $0 $-30,470 $-7,164 $-7,273
Purchase Of PPE $0 $-30,470 $-7,164 $-7,273
Change In Working Capital $669,489 $-3,422,254 $2,338,501 $952,689
Change In Other Current Liabilities $-2,606,356 $-20,989,824 $-124,840 $-115,132
Change In Other Current Assets $4,662,980 $18,966,528 $-28,175 $500
Change In Payables And Accrued Expense $-1,640,864 $-534,472 $2,546,585 $1,057,903
Change In Accrued Expense $-1,281,721 $460,842 $1,486,639 $977,583
Change In Interest Payable $0 $-109,379 $1,056,849 $715,486
Change In Payable $-359,143 $-995,314 $1,059,946 $80,320
Change In Account Payable $-359,143 $-449,873 $1,059,946 $80,320
Change In Tax Payable $0 $-545,441 $0 -
Change In Income Tax Payable $0 $-545,441 $0 -
Change In Prepaid Assets $463,809 $-659,927 $-55,069 $9,418
Change In Inventory $-108,705 $0 - -
Change In Receivables $-101,375 $-204,559 $0 -
Changes In Account Receivables $-4,096 $0 - -
Other Non Cash Items $-1,414,930 $285,513 $2,599,797 $1,345,417
Stock Based Compensation $827,043 $667,682 $636,368 $246,799
Depreciation Amortization Depletion $197,260 $124,788 $242,556 $242,124
Depreciation And Amortization $197,260 $124,788 $242,556 $242,124
Amortization Cash Flow $83,486 $97,113 $4,516 $4,516
Amortization Of Intangibles $83,486 $97,113 $4,516 $4,516
Depreciation $113,774 $27,675 $238,040 $237,608
Gain Loss On Investment Securities $5,700,451 $9,441,150 $-1,259,287 $2,515,065
Net Income From Continuing Operations $-10,368,261 $-15,445,087 $-9,051,334 $-6,478,923
Common Stock Payments - $0 $-2,294 $0
Net Long Term Debt Issuance - - $2,745,974 $1,124,299
Long Term Debt Issuance - - $2,745,974 $1,124,299
Change In Other Working Capital - - $-124,840 $-115,132
Fetched: 2026-02-02